U.S. Markets closed

Universal Biosensors, Inc. (UBI.AX)


ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.410.00 (0.00%)
At close: 11:19AM AEST

Universal Biosensors, Inc.

1 Corporate Avenue
Rowville, VIC 3178
Australia
61 3 9213 9000
http://www.universalbiosensors.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees83

Key Executives

NameTitlePayExercisedAge
Mr. Andrew Leslie Denver BSc (Hons), MBA, FAICDExec. Chairman and Interim Chief Exec. Officer336.97kN/A68
Mr. Salesh Balak BA, CAChief Financial Officer378.03kN/A48
Mr. Garry ChambersVP - Technology Devel.393.78kN/A53
Dr. Alastair McIndoe Hodges BSc. (Hons), Ph.D.Chief Scientist393.78kN/A57
Dr. Adrian Oates BSc, MSc (Preliminary), Ph.D.VP - Quality & Regulatory382.84kN/A56
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a medical diagnostics company in Australia. It focuses on the research, development, and manufacture of in vitro diagnostic test devices for consumer and professional point-of-care use. The company uses electrochemical cell technology platform to develop point-of-care testing systems for various markets. Its principal products and services include Prothrombin Time International Normalized Ratio coagulation test strips; and other electrochemical-cell based tests based on enzymatic, immunoassay, and molecular diagnostic methods. Universal Biosensors, Inc. has collaboration agreement with Siemens Healthcare Diagnostics Inc. to develop coagulation related products for hospital point-of-care and ambulatory care coagulation markets. The company was founded in 2001 and is based in Rowville, Australia.

Corporate Governance

Universal Biosensors, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.